Home NDC 21695-783 Lidocaine Hydrochloride
Product NDC 21695-783
11-digit product format 216950783
Labeler code 21695
Product ID 21695-783_8a4c45c0-7eae-4296-ae2e-6d618228dc8b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lidocaine Hydrochloride
Dosage form SOLUTION
Route ORAL; TOPICAL
Labeler Rebel Distributors Corp
Application ANDA040014
Marketing category ANDA
Marketing start 1995-07-10
Marketing end 0000-00-00
Substance LIDOCAINE HYDROCHLORIDE
Active strength 20 mg/mL
Pharmacologic classes Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 21695-783-00 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 21695-783-00 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 21695-783-00 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 21695-783-00 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 21695-783-00 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 21695-783-00 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 21695-783-00 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 21695-783-00 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 21695-783-00 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 21695-783-00 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 21695-783-00 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 21695-783-00 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 21695-783-00 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 21695-783-00 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 21695-783-00 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 21695-783-00 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 21695-783-00 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 21695-783-00 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 21695-783-00 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 21695-783-00 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 21695-783-00 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 21695-783-00 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A040014-001 LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT 1995-07-10 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT 1995-07-10 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT 1995-07-10 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT 1995-07-10 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL 1995-07-10 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A040014-001 LIDOCAINE HYDROCHLORIDE 2% SOLUTION / ORAL AT RS 1995-07-10 cb3db0bc1861…
Observed Orange Book normalized TE history# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.